<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">87</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:A116C711-4C18-5A38-8F1E-5E97753A8A64</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Folia Medica</journal-title>
        <abbrev-journal-title xml:lang="en">FM</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0204-8043</issn>
      <issn pub-type="epub">1314-2143</issn>
      <publisher>
        <publisher-name>Plovdiv Medical University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/folmed.65.e73081</article-id>
      <article-id pub-id-type="publisher-id">73081</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Chemistry &amp; biophysics</subject>
          <subject>Infectious diseases</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Clostridium difficile</italic> toxins impact on rat colon smooth muscle reactivity</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Vassilev</surname>
            <given-names>Petar</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Zaytseva</surname>
            <given-names>Ekaterina</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Ardasheva</surname>
            <given-names>Raina</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Turiyski</surname>
            <given-names>Valentin</given-names>
          </name>
          <email xlink:type="simple">valentin.turiyski@mu-plovdiv.bg</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line>Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria</addr-line>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line>Clinic of Infectious Diseases and Parasitology, St George University Hospital, Plovdiv, Bulgaria</addr-line>
      </aff>
      <aff id="A3">
        <label>3</label>
        <addr-line>Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, Plovdiv, Bulgaria</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Valentin Turiyski, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vassil Aprilov Blvd., 4002 Plovdiv, Bulgaria; Email: <email xlink:type="simple">valentin.turiyski@mu-plovdiv.bg</email>; <email xlink:type="simple">Tel</email>.: +<email xlink:type="simple">359</email><email xlink:type="simple">887</email><email xlink:type="simple">260</email><email xlink:type="simple">277</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>02</month>
        <year>2023</year>
      </pub-date>
      <volume>65</volume>
      <issue>1</issue>
      <fpage>116</fpage>
      <lpage>123</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/43648F18-1838-5885-A640-F03BABE8C000">43648F18-1838-5885-A640-F03BABE8C000</uri>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>08</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>02</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Petar Vassilev, Ekaterina Zaytseva, Raina Ardasheva, Valentin Turiyski</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p><bold>Aim</bold>: The present study was conducted in an attempt to find possible direct mechanisms of action of <italic>Clostridium difficile</italic> toxins A and B (<abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EVE">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EZE">TCdB</abbrev>) on contractility of isolated rat intestinal smooth muscles, as the contractive pathways affected by the toxins and responsible for motility disorders remain unclear.</p>
        <p><bold>Materials and methods</bold>: Adult male Wistar rats were used in our experiments. Longitudinal smooth muscle (SM) preparations of proximal colon were isolated and their contractile activity was isometrically registered. The samples were mounted in tissue baths and exogenously treated with acetylcholine (<abbrev xlink:title="acetylcholine" id="ABBRID0EBF">ACh</abbrev>), serotonin (5-HT), dopamine, norepinephrine, <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EFF">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EJF">TCdB</abbrev>. The potential of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ENF">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0ERF">TCdB</abbrev> to affect the action of these mediators on SM activity was examined.</p>
        <p><bold>Results</bold>: The experiments have shown that exciting action of <abbrev xlink:title="acetylcholine" id="ABBRID0EZF">ACh</abbrev> and 5-HT on colonic contractility is enhanced by <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0E4F">TCdA</abbrev> rather than <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EBG">TCdB</abbrev>. Conversely, relaxing effect of dopamine and norepinephrine on contractile activity of colonic SM is under impact of <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EFG">TCdB</abbrev> but not TcdA. <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EJG">TCdA</abbrev> has a stronger direct effect on <italic>in vitro</italic> SM sensitivity to <abbrev xlink:title="acetylcholine" id="ABBRID0EPG">ACh</abbrev> and 5-HT than <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0ETG">TCdB</abbrev>.</p>
        <p><bold>Conclusions</bold>: <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0E2G">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0E6G">TCdB</abbrev> affect directly the contractile reactivity of isolated rat colon smooth muscle. <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EDH">TCdA</abbrev> has a stronger direct effect on smooth muscle sensitivity to acetylcholine and 5-HT than <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EHH">TCdB</abbrev>. Such a trend has not been established for dopamine and norepinephrine.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>
          <italic>Clostridium difficile</italic>
        </kwd>
        <kwd>rat</kwd>
        <kwd>smooth muscle</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="" id="SECID0EUH">
        <title/>
        <p>Vassilev P, Zaytseva E, Ardasheva R, Turiyski V. <italic>Clostridium difficile</italic> toxins impact on rat colon smooth muscle reactivity. Folia Med (Plovdiv) 2023;65(1):116-123. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3897/folmed.65.e73081">10.3897/folmed.65.e73081</ext-link>.</p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="Introduction" id="SECID0EDAAC">
      <title>Introduction</title>
      <p>The predominant sample of published experimental data concerning in vitro studies on <italic>Clostridium difficile</italic>-targeted tissues offers unclear hypotheses about the effect of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ELAAC">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EPAAC">TCdB</abbrev> on SM contractile apparatus. Numerous studies apply an in vitro approach to elucidate the mechanisms of action of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ETAAC">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EXAAC">TCdB</abbrev>. Conceptual similarities with the present work are found in projects that impose current ideas about changes in SM activity under the influence of toxins produced by <italic>Clostridium difficile</italic>. Ex vivo experiments with isolated intestinal muscle strips<sup>[<xref ref-type="bibr" rid="B1">1</xref>]</sup> have shown changes in contractile activity after treatment with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EEBAC">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EIBAC">TCdB</abbrev>.</p>
      <p>Under such conditions, the autogenous regulation of contractility (the stimulated contraction in areas with muscle wall overstretching) is disrupted. It reflects on the superposition of myogenically generated peristaltic rhythms. As expected, a consequence of this is the impaired intestinal resorption. Such contractile changes of the colon lead to impaired water metabolism and, accordingly, to impaired formation of fecal masses and change in evacuation.<sup>[<xref ref-type="bibr" rid="B2">2</xref>]</sup></p>
      <p>In such contractile disorders, it should be of some interest to find out to what extent the intramural neuronal regulation<sup>[<xref ref-type="bibr" rid="B3">3</xref>]</sup> is able to compensate for them. We conducted ex vivo experiments using some major mediators modulating tract functions. The concept of the experiments included taking into account possible changes in the reactivity of SM isolated from rat colon and treated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0E4BAC">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EBCAC">TCdB</abbrev>. The dominant modulator of the bioelectrical and contractile activity of the gastrointestinal muscles is <abbrev xlink:title="acetylcholine" id="ABBRID0EFCAC">ACh</abbrev><sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup>, released from the parasympathetic part of the autonomic splanchnic innervation. Some authors<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> point to the cholinergic system as predominantly influenced by the action of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EWCAC">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0E1CAC">TCdB</abbrev>.</p>
    </sec>
    <sec sec-type="Aim" id="SECID0E5CAC">
      <title>Aim</title>
      <p>The aim of the study was to clear up possible direct mechanisms of action of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EEDAC">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EIDAC">TCdB</abbrev> on contractility of isolated rat intestinal smooth muscles.</p>
    </sec>
    <sec sec-type="materials|methods" id="SECID0EMDAC">
      <title>Materials and methods</title>
      <p>we used 38 adult male Wistar rats weighing 250–320 g in the experiments. The requirements set out in Directive 86/609/EEC for accommodation and care of experimental animals were fully met. The animals were housed under standard living conditions: temperature 23±1°C, change of light and dark – 12/12 hours, relative humidity about 45%. Approximately 12 hours before the start of experiments, the rats were separated from food.</p>
      <p>We obtained permission for the study from the Bulgarian Food Safety Agency: Permission No. 116 for the use of animals in experiments. The experimental work was approved by the Commission for Scientific Ethics at the Medical University of Plovdiv with protocol No. 2/13.06.2019.</p>
      <sec sec-type="Smooth muscle preparations" id="SECID0ESDAC">
        <title>Smooth muscle preparations</title>
        <p>SM preparations were excised in situ, separating the muscle tissue without mucosa as follows: a section with a length of about 3-4 cm was previously isolated from a proximal colon (2.5 cm after caecum). The longitudinal preparations of the colon used to record the contractile activity were 15-18 mm long and 1.0-1.1 mm wide. The circular intestinal strips had a length equal to the circumference of the intestinal wall in the respective region of the tract and a width of 1.0-1.2 mm. During dissection, SM tissues were washed with a preparation solution containing NaCl/ KCl/CaCl<sub>2</sub> in the ratio of 27.2:1.1:1.</p>
        <p>During the experiment, the SM preparations were fixed in a tissue bath with Krebs solution (pH=7.4, t°=37°C) with the following content (mmol/L): NaCl – 120; KCl – 5.9; CaCl<sub>2</sub> – 2.5; MgCl<sub>2</sub> – 1.2; NaH<sub>2</sub>PO<sub>4</sub> – 1.2; NaHCO – 15.4, and glucose – 11.5. All chemicals used to make the solution are manufactured by Merck. The pH of the solution was measured using a pH meter (HANNA). Krebs solution in contact with the SM preparations was aerated continuously during the experiment with a gas mixture O<sub>2</sub>/CO<sub>2</sub> in the ratio of 19/1 (v/v).</p>
      </sec>
      <sec sec-type="Treatment of muscle preparations" id="SECID0EIEAC">
        <title>Treatment of muscle preparations</title>
        <p>Isolated SM were exogenously treated with <abbrev xlink:title="acetylcholine" id="ABBRID0EOEAC">ACh</abbrev>, 5-HT, dopamine, and norepinephrine by adding a precisely defined volume of concentrated solution of the respective substance necessary to achieve the desired concentration in the tissue bath (1.10<sup>-6</sup> mol/L). The volume did not exceed 1/100 of the volume of the solution in the tissue bath. The vitality of SM tissue was tested by exposure to 1.10<sup>-6</sup> mol/L <abbrev xlink:title="acetylcholine" id="ABBRID0EWEAC">ACh</abbrev> at the beginning of each experiment twice, after adaptation period of 60 minutes.</p>
      </sec>
      <sec sec-type="Assay of mechanical activity of smooth muscle preparations" id="SECID0E1EAC">
        <title>Assay of mechanical activity of smooth muscle preparations</title>
        <p>Mechanical activity was recorded isometrically quantifying the contractile reactions in mN. The SM preparations were fixed to a glass holder at one end and to Swema strain gauges (Stockholm, Sweden) at the other by surgical sutures, with the gauges converting the mechanical deformation produced by contractile activity into a proportional electrical signal.</p>
        <p>The initial mechanical stress for the preparations achieved by tensioning had a value corresponding to a force of 10 mN. The adaptation period to establish a baseline level of tone and regular spontaneous contractile activity was 60 minutes during which time the Krebs solution was changed two or three times. Changes in spontaneous mechanical activity and tone caused by exposure to various substances were reported relative to the corresponding baseline. Strength and frequency of phasic activity were defined as the mean of a large number of consecutive contractions (about 10).</p>
        <p>The electrical signal from the strain gauges was amplified by K. Tesar-D 486 (Germany). The recording of mechanical activity on paper tape was performed using a Linseis recorder (Selb, Germany).</p>
      </sec>
      <sec sec-type="Assay of smooth muscle tissue response to Clostridium difficile toxins" id="SECID0EBFAC">
        <title>Assay of smooth muscle tissue response to <italic>Clostridium difficile</italic> toxins</title>
        <p>Pre-dissolved in distilled water, the toxins were added to the Krebs solution (at standard conditions) in the tissue bath at the appropriate volume ratio to achieve the required concentration of TcdA – 1.10<sup>-8</sup> mol/L and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EMFAC">TCdB</abbrev> – 1.10<sup>-8</sup> mol/L. After that, the incubation lasted 3 hours, and the incubation medium was replaced with fresh Krebs solution.</p>
      </sec>
      <sec sec-type="Presentation of results and statistical processing" id="SECID0ESFAC">
        <title>Presentation of results and statistical processing</title>
        <p>The results obtained from the experiments were statistically analyzed using STATISTICA 12.0 (StatSoft, Tulsa, Oklahoma). The analysis was performed on groups of independent or dependent variables determined by the type of experiment. The final values were presented as mean ± standard error. The value of Student’s coefficient <italic>p</italic>&lt;0.05 is accepted as criterion for significant difference.</p>
      </sec>
    </sec>
    <sec sec-type="Results" id="SECID0E1FAC">
      <title>Results</title>
      <sec sec-type="Effects of ACh (1.10-6 mol/L) on the contractile activity of isolated smooth muscle preparations from colon circulum and colon longitudinalis" id="SECID0E5FAC">
        <title>Effects of ACh (1.10<sup>-6</sup> mol/L) on the contractile activity of isolated smooth muscle preparations from colon circulum and colon longitudinalis.</title>
        <sec sec-type="Colon circulum" id="SECID0EJGAC">
          <title>
            <italic>Colon circulum</italic>
          </title>
          <p>In control preparations, administration of <abbrev xlink:title="acetylcholine" id="ABBRID0ESGAC">ACh</abbrev> elicited a contractile response of 2.04±0.34 mN (n=20) without significant changes in the amplitude of the phase contractions (n-number of SM strips used in a given group) <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
          <fig id="F1" position="float" orientation="portrait">
            <object-id content-type="arpha">C0B9BD44-4C10-598F-8698-810378AFD3E2</object-id>
            <label>Figure 1.</label>
            <caption>
              <p>Contractile responses of isolated SM preparations to exogenously administered <abbrev xlink:title="acetylcholine" id="ABBRID0EFHAC">ACh</abbrev> (1.10<sup>-6</sup> mol/L). CCC: circular column – control; CCA: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ELHAC">TCdA</abbrev>; CCB: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EPHAC">TCdB</abbrev>; CLC: longitudinal column – control; CLA: longitudinal column incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ETHAC">TCdA</abbrev>; CLB: longitudinal column with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EXHAC">TCdB</abbrev>. Significant differences compared to the control responses were indicated by * (<italic>p</italic>&lt;0.05).</p>
            </caption>
            <graphic xlink:href="foliamedica-65-1-e73081-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_822987.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/822987</uri>
            </graphic>
          </fig>
          <p>Incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EGIAC">TCdA</abbrev> SM preparations (n=18) responded to exogenously administered <abbrev xlink:title="acetylcholine" id="ABBRID0EKIAC">ACh</abbrev> with a contraction of 2.63±0.44 mN, significantly increased compared to the control (<italic>p</italic>&lt;0.05), without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
          <p>Incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0E2IAC">TCdB</abbrev> SM preparations (n=10) responded to exogenously administered <abbrev xlink:title="acetylcholine" id="ABBRID0E6IAC">ACh</abbrev> with a contraction of 2.01±0.71 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
        </sec>
        <sec sec-type="Colon longitudinalis" id="SECID0EKJAC">
          <title>
            <italic>Colon longitudinalis</italic>
          </title>
          <p>In the control preparations, the application of acetylcholine elicited a contractile response of 3.71±0.8 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
          <p>The SM preparations (n=15) incubated with 1.10<sup>-‌8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0E5JAC">TCdA</abbrev> responded to exogenously administered <abbrev xlink:title="acetylcholine" id="ABBRID0ECKAC">ACh</abbrev> with a contraction of 5.96±0.7 mN significantly increased compared to the control (<italic>p</italic>&lt;0.05) without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0ETKAC">TCdB</abbrev> responded to exogenously administered <abbrev xlink:title="acetylcholine" id="ABBRID0EXKAC">ACh</abbrev> with a contraction of 3.59±0.71 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
        </sec>
      </sec>
      <sec sec-type="Effects of 5-HT (1.10-6 mol/L) on the contractile activity of isolated smooth muscle preparations from colon circulum and colon longitudinalis" id="SECID0ECLAC">
        <title>Effects of 5-HT (1.10<sup>-6</sup> mol/L) on the contractile activity of isolated smooth muscle preparations from colon circulum and colon longitudinalis.</title>
        <sec sec-type="Colon circulum" id="SECID0EJLAC">
          <title>
            <italic>Colon circulum</italic>
          </title>
          <p>In control preparations, administration of 5-HT elicited a contractile response of 2.41±0.436 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
          <fig id="F2" position="float" orientation="portrait">
            <object-id content-type="arpha">DA2ED56E-5A1B-512C-89DF-243C7A7FAB5D</object-id>
            <label>Figure 2.</label>
            <caption>
              <p>Contractile responses of isolated SM preparations to exogenously administered 5-HT (1.10<sup>-6</sup> mol/L). CCC: circular column – control; CCA: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EDMAC">TCdA</abbrev>; CCB: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EHMAC">TCdB</abbrev>; CLC: longitudinal colon – control; CLA: longitudinal colon incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ELMAC">TCdA</abbrev>; CLB: longitudinal colon incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EPMAC">TCdB</abbrev>. Significant differences in reactions compared to the control were indicated by * (<italic>p</italic>&lt;0.05).</p>
            </caption>
            <graphic xlink:href="foliamedica-65-1-e73081-g002.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_822988.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/822988</uri>
            </graphic>
          </fig>
          <p>The SM preparations (n=18) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0E5MAC">TCdA</abbrev> responded to exogenously administered 5-HT with a contraction of 1.25±0.64 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0ENNAC">TCdB</abbrev> responded to exogenously administered 5-HT with a contraction of 2.02±0.92 mN without changes in the amplitude of phase reductions <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
        </sec>
        <sec sec-type="Colon longitudinalis" id="SECID0EYNAC">
          <title>
            <italic>Colon longitudinalis</italic>
          </title>
          <p>In control preparations, administration of 5-HT elicited a contractile response of 1.89±0.46 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
          <p>The SM preparations (n=15) incubated with 1.10<sup>-8</sup> mol/LTCdA responded to exogenously administered 5-HT with a contraction of 3.24±0.61 mN, significantly increased compared to the control (<italic>p</italic>&lt;0.05) without changes in the amplitude of phase reductions <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EZOAC">TCdB</abbrev> responded to exogenously administered 5-HT with a contraction of 3.88±1.97 mN without changes in the amplitude of phase reductions <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
        </sec>
      </sec>
      <sec sec-type="Effects of dopamine (1.10-6 mol/L) on contractile activity of isolated smooth muscle preparations from colon circulum and colon longitudinalis" id="SECID0EEPAC">
        <title>Effects of dopamine (1.10<sup>-6</sup> mol/L) on contractile activity of isolated smooth muscle preparations from colon circulum and colon longitudinalis.</title>
        <sec sec-type="Colon circulum" id="SECID0ELPAC">
          <title>
            <italic>Colon circulum</italic>
          </title>
          <p>In control preparations, administration of dopamine elicited a relaxation response of −2.41±0.43 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>.</p>
          <fig id="F3" position="float" orientation="portrait">
            <object-id content-type="arpha">6D7684BB-4D37-5808-B4B1-95F5AB1A7430</object-id>
            <label>Figure 3.</label>
            <caption>
              <p>Reduction responses of isolated SM preparations to exogenously administered dopamine (1.10<sup>-6</sup> mol/L). CCC: circular column – control; CCA: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EGAAE">TCdA</abbrev>; CCB: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EKAAE">TCdB</abbrev>; CLC: longitudinal colon – control; CLA: longitudinal colon incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EOAAE">TCdA</abbrev>; CLB: longitudinal colon incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0ESAAE">TCdB</abbrev>. Significant differences in reactions compared to the control were indicated by * (<italic>p</italic>&lt;0.05).</p>
            </caption>
            <graphic xlink:href="foliamedica-65-1-e73081-g003.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_822989.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/822989</uri>
            </graphic>
          </fig>
          <p>The SM preparations (n=18) incubated with 1.10<sup>-‌8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EBBAE">TCdA</abbrev> responded to exogenously administered dopamine with a relaxation of −1.25±0.64 mN (<italic>p</italic>&gt;0.05) without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0ESBAE">TCdB</abbrev> responded to exogenously administered dopamine with a relaxation of −3.88±1.97 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>.</p>
        </sec>
        <sec sec-type="Colon longitudinalis" id="SECID0E4BAE">
          <title>
            <italic>Colon longitudinalis</italic>
          </title>
          <p>In control preparations, administration of dopamine elicited a relaxation response of −0.87±0.1 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>.</p>
          <p>The SM preparations (n=15) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ERCAE">TCdA</abbrev> responded to exogenously administered dopamine with a relaxation of −0.35±0.45 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EADAE">TCdB</abbrev> responded to exogenously administered dopamine with a relaxation of −1.09±0.3 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F3">3</xref>)</bold>.</p>
        </sec>
      </sec>
      <sec sec-type="Effects of norepinephrine (1.10-6 mol/L) on contractile activity of isolated smooth muscle preparations from the colon circulum and colon longitudinalis" id="SECID0ELDAE">
        <title>Effects of norepinephrine (1.10<sup>-6</sup> mol/L) on contractile activity of isolated smooth muscle preparations from the colon circulum and colon longitudinalis</title>
        <sec sec-type="Colon circulum" id="SECID0ESDAE">
          <title>
            <italic>Colon circulum</italic>
          </title>
          <p>In control preparations, administration of norepinephrine elicited a relaxation response of −0.68±0.03 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>.</p>
          <fig id="F4" position="float" orientation="portrait">
            <object-id content-type="arpha">76285426-DBB5-554D-A1F6-DEBBC9C5FCB2</object-id>
            <label>Figure 4.</label>
            <caption>
              <p>Reduction responses of isolated SM preparations to exogenously administered norepinephrine (1.10<sup>-6</sup> mol/L). CCC: circular column – control; CCA: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EMEAE">TCdA</abbrev>; CCB: circular column incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EQEAE">TCdB</abbrev>; CLC: longitudinal colon – control; CLA: longitudinal colon incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EUEAE">TCdA</abbrev>; CLB: longitudinal colon incubated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EYEAE">TCdB</abbrev>. Significant differences in reactions compared to the control were indicated by * (<italic>p</italic>&lt;0.05).</p>
            </caption>
            <graphic xlink:href="foliamedica-65-1-e73081-g004.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_822990.jpg">
              <uri content-type="original_file">https://binary.pensoft.net/fig/822990</uri>
            </graphic>
          </fig>
          <p>The SM preparations (n=18) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EHFAE">TCdA</abbrev> responded to exogenously administered norepinephrine with a relaxation of −0.6±1.01 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EWFAE">TCdB</abbrev> responded to exogenously administered norepinephrine with a relaxation of −0.88±0.9 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>.</p>
        </sec>
        <sec sec-type="Colon longitudinalis" id="SECID0EBGAE">
          <title>
            <italic>Colon longitudinalis</italic>
          </title>
          <p>In control preparations, administration of norepinephrine elicited a relaxation response of −0.96±0.05 mN (n=20) without significant changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>.</p>
          <p>The SM preparations (n=15) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EVGAE">TCdA</abbrev> responded to exogenously administered norepinephrine with a relaxation of −0.63±0.14 mN without changes in the amplitude of phase contractions <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>.</p>
          <p>The SM preparations (n=10) incubated with 1.10<sup>-8</sup> mol/L <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EEHAE">TCdB</abbrev> did not respond to exogenously administered norepinephrine <bold>(Fig. <xref ref-type="fig" rid="F4">4</xref>)</bold>.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="Discussion" id="SECID0EPHAE">
      <title>Discussion</title>
      <p>Because the effects of Clostridium difficile toxins on smooth muscle contractility are a component of their overall impact on clinical phenomena, the possible mechanisms of affecting the gastrointestinal tract are of critical importance. The effects on intestinal muscle involved in the formation of segments along the small intestine (assuming that the contractility of the longitudinal muscles is not affected) should cause a change in the frequency and amplitude of segmentation. The above would lead to some disruption of the synchrony of movement of intestinal contents. This would inevitably cause atypical retention of intestinal contents in some areas and premature evacuation of others, combined with difficulty in homogenizing the masses in the intestinal lumen.<sup>[<xref ref-type="bibr" rid="B6">6</xref>]</sup></p>
      <p>The obtained results showed significant differences in the magnitude of the contractile responses to <abbrev xlink:title="acetylcholine" id="ABBRID0E4HAE">ACh</abbrev> (main parasympathetic regulator and major testing agent for muscle contractile vitality) in SM preparations incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EBIAE">TCdA</abbrev> compared to the control ones, while no differences were found in the reactions of the preparations treated with <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EFIAE">TCdB</abbrev> compared to the control ones. The contractile effects caused by <abbrev xlink:title="acetylcholine" id="ABBRID0EJIAE">ACh</abbrev> in the SM of gastrointestinal tract are mainly the result of activation of the M<sub>3</sub>-cholinergic receptors.‌<sup>[<xref ref-type="bibr" rid="B7">7</xref>]</sup> Thus, the increase in SM tone is due to the release of Ca<sup>2+</sup> from intracellular depots.<sup>[<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>]</sup> The observed increase in contractile response in colon preparations incubated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EDJAE">TCdA</abbrev> could be a consequence of the SM membrane depolarization observed by Gilbert upon action with TcdA. <sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup> In the causal aspect, this is related to the enhancement of Ca<sup>2+</sup> influx, provoked indirectly by exogenously applied <abbrev xlink:title="acetylcholine" id="ABBRID0EQJAE">ACh</abbrev>. An argument in favor of our hypothesis is the reported increase in carbachol-induced contractions in SM treated with <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EUJAE">TCdA</abbrev>.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup> The above data suggest the presence of prerequisites for enhanced sensitivity of the muscles of the gastrointestinal tract to the regulatory function of <abbrev xlink:title="acetylcholine" id="ABBRID0E6JAE">ACh</abbrev>.</p>
      <p>The lack of significant changes in <abbrev xlink:title="acetylcholine" id="ABBRID0EFKAE">ACh</abbrev>-induced responses in <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EJKAE">TCdB</abbrev>-incubated preparations should be analyzed on the background of data existing<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup>, namely: significant likelihood of TcdB inactivating Rho proteins involved in modulation of the contractile apparatus; regulating the activity of phospholipase D, with a negligible effect on the activity of protein kinase C as well as pronounced inhibitory effect on muscarinic receptor activity.<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup></p>
      <p>The tests to determine the effect of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0E3KAE">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EALAE">TCdB</abbrev> on 5-HT mediation were performed according to the same scheme as in the experiments with <abbrev xlink:title="acetylcholine" id="ABBRID0EELAE">ACh</abbrev>. It was established that circular SM colon preparations demonstrated resistance to 5-HT-induced reactions in the presence of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EILAE">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EMLAE">TCdB</abbrev>. Rise of contractile reaction in the presence of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EQLAE">TCdA</abbrev> was observed in longitudinal preparations.</p>
      <p>Enteroendocrine cells are known to act as pressure sensors secreting 5-HT that initiates peristaltic reflexes.<sup>[<xref ref-type="bibr" rid="B13">13</xref>]</sup> The contraction-relaxation processes provoked by 5-HT through interneuronal interactions involve acetylcholine, substance P, nitric oxide (<abbrev xlink:title="nitric oxide" id="ABBRID0E4LAE">NO</abbrev>), vasoactive intestinal peptide (<abbrev xlink:title="vasoactive intestinal peptide" id="ABBRID0EBMAE">VIP</abbrev>), and calcitonin gene-regulating peptide.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup> The activation of Rho-protein and Rho-kinase is most probably a leading factor in the generation of 5-HT-induced contractions.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> Meanwhile, a major regulatory link in the contractility chain – protein kinase C, plays a minor role in the development of these processes.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> Our observations in this aspect contradict Lucius’ hypothesis about the negative effect of 5-HT on the contractile activity of the longitudinal intestinal muscles in experimental animals.<sup>[<xref ref-type="bibr" rid="B16">16</xref>]</sup></p>
      <p>Gastrointestinal expression and function of 5-HT receptors are specific on different levels of the gastrointestinal tract in rats. 5-HT<sub>7</sub>-receptor activation causes relaxation of SM probably through activation of cyclic nucleotides, whereas 5-HT<sub>2B</sub>-receptors mediate the contractions. The other expressed type – 5-HT<sub>4</sub>-receptor is likely to participate in both inhibition and activation of SM. Parallel neural and myogenic processes are involved in above mentioned effects.<sup>[<xref ref-type="bibr" rid="B17">17</xref>]</sup></p>
      <p>It remains unclear why the contractile reactivity of the longitudinal muscles in the area of the proximal colon is affected by <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EQNAE">TCdA</abbrev> intoxication while the contractile reactivity of the circular ones is not. It is likely that there are differences in the interneuronal interactions of serotonergic mediation leading to the release of <abbrev xlink:title="acetylcholine" id="ABBRID0EUNAE">ACh</abbrev>, substance P, <abbrev xlink:title="nitric oxide" id="ABBRID0EYNAE">NO</abbrev>, and <abbrev xlink:title="vasoactive intestinal peptide" id="ABBRID0E3NAE">VIP</abbrev> in the submucosal, and myenteric intramural plexuses.<sup>[<xref ref-type="bibr" rid="B3">3</xref>]</sup></p>
      <p>In contrast to the contractile character of effects caused by <abbrev xlink:title="acetylcholine" id="ABBRID0EIOAE">ACh</abbrev> and 5-HT, exogenously administered dopamine relaxes the SM of the colon. The magnitude of the effect is different in circular and longitudinal preparations; it is significantly weaker reaction in the latter. Applied to isolated SM from rat colon, dopamine induces a relaxation, which at high concentrations (10<sup>-4</sup> mol/L) is accompanied by a complete loss of spontaneous contractile activity.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup> The effect is not related to direct activation of dopamine receptors but is probably mediated by β-adrenoceptors.</p>
      <p>According to other evidence of a noncholinergic neuronal origin of its relaxation effect, dopamine inhibits SM contractions in the rat colon by activating β<sub>1</sub>-adrenoceptors on intramural plexuses and by β<sub>2</sub>-receptors expressed on SM itself.<sup>[<xref ref-type="bibr" rid="B18">18</xref>]</sup> Analogous experiments have shown that the inhibitory action of dopamine involves inhibition of <abbrev xlink:title="acetylcholine" id="ABBRID0ECPAE">ACh</abbrev> release from enteric neurons mediated by D<sub>1</sub> and D<sub>2</sub>-receptors, as well as influencing <abbrev xlink:title="nitric oxide" id="ABBRID0EKPAE">NO</abbrev> activity and purinergic mediation. <sup>[<xref ref-type="bibr" rid="B19">19</xref>]</sup> Probably the dominant role in these processes is played by activation of adenylate cyclase and consequent increase in cyclic adenosine monophosphate concentration.</p>
      <p>The lack of influence of <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0EXPAE">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0E2PAE">TCdB</abbrev> on dopamine-induced relaxations in our experiments allows some speculations: on the one hand, pronounced “non-competitiveness” in the involvement of the adenylate cyclase mechanism of toxins and catecholamines, and on the other, inability to stop relaxing SM processes due to the wide range of receptor and interneuronal interactions that have been described, dopamine activates at the enteric plexus.</p>
      <p>We do not rule out that preservation of the relaxation effect caused by dopamine is the result of membrane hyperpolarization<sup>[<xref ref-type="bibr" rid="B20">20</xref>]</sup> of SM cells of the colon (concomitant enhanced K<sup>+</sup> current), which in itself turns the effect independent of specific intracellular contractile mechanisms. It was commented above that activation of β-adrenoceptors is one of the pathways leading to suppression of SM activity in the colon wall. The effect is due to increased synthesis of cyclic adenosine monophosphate, activation of protein kinase A, and blocking the ability of myosin light-chain kinase to initiate contractions.</p>
      <p>As a neuronal regulator of enteric contractile activity, the sympathetic part of the autonomic nervous system interacts in a complex pattern, both with the parasympathetic part and with the structures of the nonadrenergic and noncholinergic innervating systems. An important element of that interaction at the rat colon level is the antagonism of noradrenaline and <abbrev xlink:title="vasoactive intestinal peptide" id="ABBRID0EMQAE">VIP</abbrev> activity.<sup>[<xref ref-type="bibr" rid="B21">21</xref>]</sup> In addition, noradrenaline and adrenaline have been shown to significantly reduce the effectiveness of <abbrev xlink:title="acetylcholine" id="ABBRID0EXQAE">ACh</abbrev> in the longitudinal intestinal layer excitation. The effect is receptor-mediated (α-adrenoceptors), and it does not involve dopamine, the other catecholamine that is important for the motility.<sup>[<xref ref-type="bibr" rid="B22">22</xref>]</sup></p>
      <p>As commented above, conditions such as colitis, dysbacteremia, gastrointestinal intoxications (including <italic>Clostridium difficile</italic> intoxication), and infections affect in a similar way certain units and agents of the SM contractile system of the tract, such as <abbrev xlink:title="vasoactive intestinal peptide" id="ABBRID0EFRAE">VIP</abbrev> and <abbrev xlink:title="acetylcholine" id="ABBRID0EJRAE">ACh</abbrev>. A study using a model of chemically-induced colitis<sup>[<xref ref-type="bibr" rid="B23">23</xref>]</sup> demonstrated a significant increase in acetylcholinesterase and <abbrev xlink:title="vasoactive intestinal peptide" id="ABBRID0EURAE">VIP</abbrev> levels in the SM wall of the colon in rats.</p>
      <p>Our experimental data related to the effect of exogenous norepinephrine on isolated SMs show a weak relaxation effect in both circular and longitudinal preparations. Preliminary treatment with TcdA and TcdB did not result in changes in responses, except in the case of a longitudinal colon preparation treated with TcdB in which no reaction at all was present.</p>
      <p>An acceptable explanation for this is the above-mentioned complex intraplex interactions of sympathetic innervation, as well as the fact that the presence of norepinephrine is associated with a decrease in <abbrev xlink:title="vasoactive intestinal peptide" id="ABBRID0E2RAE">VIP</abbrev> efficacy, while when the intestinal function is impaired, the peptide levels are significantly elevated. Such antagonism of influences can serve to extrapolate the direction of development of contraction and relaxation processes. In purely quantitative terms, it should be noted that exogenously administered norepinephrine is about four times less active than adrenaline.<sup>[<xref ref-type="bibr" rid="B22">22</xref>]</sup></p>
    </sec>
    <sec sec-type="Conclusions" id="SECID0EFSAE">
      <title>Conclusions</title>
      <p>The developed experimental model provides data suggesting that <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ELSAE">TCdA</abbrev> and <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EPSAE">TCdB</abbrev> affect directly the contractile reactivity of isolated rat colon smooth muscle. <abbrev xlink:title="Clostridium difficile toxins A" id="ABBRID0ETSAE">TCdA</abbrev> exerts a stronger direct effect on smooth muscle sensitivity to acetylcholine and 5-HT than <abbrev xlink:title="Clostridium difficile toxins B" id="ABBRID0EXSAE">TCdB</abbrev> does. Such a trend has not been established for dopamine and norepinephrine.</p>
      <p>For better understanding of the above and in order to clear some cellular mechanisms of the effects obtained, future experiments will include investigations with Real Time Cell Analyzer, which provides direct measurement of cell culture electric impedance, as well as measure of reaction of isolated smooth muscles to electrostimulation.</p>
    </sec>
    <sec sec-type="Conflict of Interests" id="SECID0E3SAE">
      <title>Conflict of Interests</title>
      <p>The authors declare that there is no conflict of interests regarding the publication of this article.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple">1. Gilbert RJ, Triadafilopoulos G, Pothoulakis C, et al. Effect of purified Clostridium difficile toxins on intestinal smooth muscle. Am J Physiol 1989; 256(4,Pt 1):759–66.</mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple">2. Wilcox M. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 2003; 17(3):475–83.</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple">3. Hansen MB. The enteric nervous system II: gastrointestinal functions. Pharmacol Toxicol 2003; 92(6):249–57.</mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple">4. Browning JG, Hardcastle J, Hardcastle PT, et al. The role of acetylcholine in the regulation of ion transport by rat colon mucosa. J Physiol 1977; 272(3):737–54.</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple">5. Gaginella TS, Grisham MB, Thomas DB, et al. Oxidant-evoked release of acetylcholine from enteric neurons of the rat colon. J Pharmacol Exp Ther 1992; 263(3):1068–73.</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple">6. Fordtran JS, Rector FC, Locklear TW, et al. Water and solute movement in the small intestine of patients with sprue. J Clin Invest 1967; 46(3):287–98.</mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple">7. Ehlert FJ, Sawyer GW, Esqueda EE. Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci 1999; 64(6-7):387–94.</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple">8. Van Koppen CJ, Kaiser B. Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 2003; 98(2):197–220.</mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple">9. Lucas JL, Wang D, Sadee W. Calmodulin binding to peptides derived from the i3 loop of muscarinic receptors. Pharm Res 2006; 23(4):647–53.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple">10. Aguilar HN, Mitchell HF. Physiological pathways and molecular mechanisms regulating uterine contractility. Hum Reprod Update 2010; 16(6):725–44.</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple">11. Schmidt M, Rümenapp U, Bienek Ch, et al. Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B: Role of Rho proteins. J Biol Chem 1996; 271(5):2422–6.</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple">12. Schmidt M, Hüwe SM, Fasselt B, et al. Mechanisms of phospholipase D stimulation by M3 muscarinic acetylcholine receptors: evidence for involvement of tyrosine phosphorylation. Eur J Biochem 1994; 225(2):667–75.</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple">13. Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2013; 20(1):14–21.</mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple">14. Hansen MB. The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol (Oxf) 2008; 193(4):311–23.</mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple">15. Nishikawa Y, Doi M, Koji T, et al. The role of Rho and Rho-dependent kinase in serotonin-induced contraction observed in bovine middle cerebral artery. Tohoku J Exp Med 2003; 201(4):239–49.</mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation xlink:type="simple">16. Lucius C, Arner A, Steusloff A, et al. Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins. J Physiol 1998; 506:83–93.</mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation xlink:type="simple">17. Wouters MM, Farrugia G, Schemann M. 5‐HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves. Neurogastroentero Motil 2007; 19:5–12.</mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation xlink:type="simple">18. Ek BA, Bjellin LA, Lundgren BT. Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity. Gastroenterology 1986; 90(2):400–7.</mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation xlink:type="simple">19. Auteri M, Zizzo MG, Amato A, et al. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors. J Physiol Biochem 2016; 73(3):395–404.</mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation xlink:type="simple">20. Al-Jahmany AA, Schultheiss G, Diener M. Effects of dopamine on ion transport across the rat distal colon. Pflugers Arch 2004; 448(6):605–12.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation xlink:type="simple">21. Bhaskar M, O’Dorisio T, Cataland S, et al. Angiotensin II and norepinephrine antagonize the secretory effect of VIP in rat ileum and colon. Peptides 1984; 5(2):291–4.</mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation xlink:type="simple">22. Paton WD, Vizi ES. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol 1969; 35(1):10–28.</mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation xlink:type="simple">23. Kishimoto S, Haruma K, Tari A, et al. Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats. Dig Dis Sci 2000; 45(8):1608–16.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
